Related Experiment Video
Updated: May 12, 2026

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
Published on: May 11, 2018
Reversible disruption of mSWI/SNF (BAF) complexes by the SS18-SSX oncogenic fusion in synovial sarcoma
Cigall Kadoch1, Gerald R Crabtree
1Program in Cancer Biology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract:
Recent exon sequencing studies have revealed that over 20% of human tumors have mutations in subunits of mSWI/SNF (BAF) complexes. To investigate the underlying mechanism, we studied human synovial sarcoma (SS), in which transformation results from the translocation of exactly 78 amino acids of SSX to the SS18 subunit of BAF complexes. We demonstrate that the SS18-SSX fusion protein competes for assembly with wild-type SS18, forming an altered complex lacking the tumor suppressor BAF47 (hSNF5). The altered complex binds the Sox2 locus and reverses polycomb-mediated repression, resulting in Sox2 activation. Sox2 is uniformly expressed in SS tumors and is essential for proliferation. Increasing the concentration of wild-type SS18 leads to reassembly of wild-type complexes retargeted away from the Sox2 locus, polycomb-mediated repression of Sox2, and cessation of proliferation. This mechanism of transformation depends on only two amino acids of SSX, providing a potential foundation for therapeutic intervention.
Insights
Mutations in SWI/SNF (BAF) complexes are common in human cancers. In synovial sarcoma, the SS18-SSX fusion protein disrupts BAF complexes, activating the Sox2 gene and driving tumor growth.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Over 20% of human tumors harbor mutations in SWI/SNF (BAF) complexes.
- Synovial sarcoma (SS) is characterized by a specific translocation involving the SS18 and SSX genes.
Purpose of the Study:
- To elucidate the molecular mechanism by which the SS18-SSX fusion protein drives synovial sarcoma.
- To investigate the role of BAF complexes and Sox2 in SS pathogenesis.
Main Methods:
- Studied human synovial sarcoma (SS) cell models.
- Analyzed the assembly of BAF complexes and their interaction with the Sox2 locus.
- Assessed the impact of SS18-SSX on polycomb-mediated repression and Sox2 activation.
Main Results:
- The SS18-SSX fusion protein forms an aberrant BAF complex lacking BAF47 (hSNF5).
- This altered complex targets the Sox2 locus, reversing repression and leading to Sox2 activation, which is crucial for SS proliferation.
- Restoring wild-type SS18 levels reassembles functional BAF complexes, represses Sox2, and halts proliferation.
Conclusions:
- The SS18-SSX fusion protein hijacks BAF complexes to activate Sox2, a key driver of synovial sarcoma.
- This oncogenic mechanism is dependent on a minimal SSX sequence, suggesting a targeted therapeutic approach.
More Related Videos
09:49Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing
Published on: July 5, 2019
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...